|
| Geneenvironment interactions and predictors of breast cancer in familybased multiethnic groups |
|
https://doi.org/10.18632/oncotarget.25520
Mildred C. Gonzales, James Grayson, Amanda Lie, Chong Ho Yu, and Shyang-Yun Pamela K. Shiao
|
| 29019-29035 |
|
| The immunerelated microRNA miR146b is upregulated in glioblastoma recurrence |
|
https://doi.org/10.18632/oncotarget.25528
Shariq S. Khwaja, Chunyu Cai, Shahed N. Badiyan, Xiaowei Wang, and Jiayi Huang
|
| 29036-29046 |
|
| Oral inflammation promotes oral squamous cell carcinoma invasion |
|
https://doi.org/10.18632/oncotarget.25540
Cameron Goertzen, Hayder Mahdi, Catherine Laliberte, Tomer Meirson, Denise Eymael, Hava Gil-Henn, and Marco Magalhaes
|
| 29047-29063 |
|
| A multiomics analysis of S100 protein family in breast cancer |
|
https://doi.org/10.18632/oncotarget.25561
Patrizia Cancemi, Miriam Buttacavoli, Gianluca Di Cara, Nadia Ninfa Albanese, Serena Bivona, Ida Pucci-Minafra, and Salvatore Feo
|
| 29064-29081 |
|
| An evaluation in vitro of the efficacy of nutlin3 and topotecan in combination with 177LuDOTATATE for the treatment of neuroblastoma |
|
https://doi.org/10.18632/oncotarget.25607
Mathias Tesson, Richa Vasan, Andreas Hock, Colin Nixon, Colin Rae, Mark Gaze, and Robert Mairs
|
| 29082-29096 |
|
| InDePTH: detection of hub genes for developing gene expression networks under anticancer drug treatment |
|
https://doi.org/10.18632/oncotarget.25624
Masaru Koido, Yuri Tani, Satomi Tsukahara, Yuka Okamoto, and Akihiro Tomida
|
| 29097-29111 |
|
| Resveratrol prevents p53 aggregation in vitro and in breast cancer cells |
|
https://doi.org/10.18632/oncotarget.25631
Danielly C. Ferraz da Costa, Nathali P.C. Campos, Ronimara A. Santos, Francisca Hildemagna Guedes-da-Silva, Mafalda Maria D.C. Martins-Dinis, LetÃcia Zanphorlin, Carlos Ramos, Luciana P. Rangel, and Jerson L. Silva
|
| 29112-29122 |
|
| Integrative landscape of dysregulated signaling pathways of clinically distinct pancreatic cancer subtypes |
|
https://doi.org/10.18632/oncotarget.25632
Musalula Sinkala, Nicola Mulder, and Darren Patrick Martin
|
| 29123-29139 |
|
| PARP1Erk synergism in proliferating cells |
|
https://doi.org/10.18632/oncotarget.25633
Leonid Visochek, and Malka Cohen-Armon
|
| 29140-29145 |
|
| Regulation of the interferongamma IFNγ pathway by p63 and Δ133p53 isoform in different breast cancer subtypes |
|
https://doi.org/10.18632/oncotarget.25635
Sunali Y. Mehta, Brianna C. Morten, Jisha Antony, Luke Henderson, Annette Lasham, Hamish Campbell, Heather Cunliffe, Julia A. Horsfield, Roger R. Reddel, Kelly A. Avery-Kiejda, Cristin G. Print, and Antony W. Braithwaite
|
| 29146-29161 |
|
| Collaborating genomic transcriptomic and microbiomic alterations lead to canine extreme intestinal polyposis |
|
https://doi.org/10.18632/oncotarget.25646
Jin Wang, Tianfang Wang, Micah A. Bishop, John F. Edwards, Hang Yin, Stephen Dalton, Laura K. Bryan, and Shaying Zhao
|
| 29162-29179 |
|
| Survivin as a potential therapeutic target of acetylsalicylic acid in pituitary adenomas |
|
https://doi.org/10.18632/oncotarget.25650
Kinga Németh, Nikolette Szücs, Sándor Czirják, Lilla Reiniger, Borbála Szabó, Gábor Barna, Katalin Karászi, Péter Igaz, Vladimir Zivkovic, Márta Korbonits, Attila Patócs, and Henriett Butz
|
| 29180-29192 |
|
| BET inhibition in advanced cutaneous T cell lymphoma is synergistically potentiated by BCL2 inhibition or HDAC inhibition |
|
https://doi.org/10.18632/oncotarget.25670
Sa Rang Kim, Julia M. Lewis, Benoit M. Cyrenne, Patrick F. Monico, Fatima N. Mirza, Kacie R. Carlson, Francine M. Foss, and Michael Girardi
|
| 29193-29207 |
|
| Circular RNA CpG island hypermethylationassociated silencing in human cancer |
|
https://doi.org/10.18632/oncotarget.25673
Humberto J. Ferreira, Veronica Davalos, Manuel Castro de Moura, Marta Soler, Montserrat Perez-Salvia, Alberto Bueno-Costa, Fernando Setien, Sebastian Moran, Alberto Villanueva, and Manel Esteller
|
| 29208-29219 |
|
| Development of an integrated CRISPRi targeting ΔNp63 for treatment of squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.25678
Masakazu Yoshida, Etsuko Yokota, Tetsushi Sakuma, Tomoki Yamatsuji, Nagio Takigawa, Toshikazu Ushijima, Takashi Yamamoto, Takuya Fukazawa, and Yoshio Naomoto
|
| 29220-29232 |
|
| Evaluation of modified carbapenem inactivation method for suspected carbapenemase among Enterobacteriaceae clinical isolates |
|
https://doi.org/10.18632/oncotarget.25603
Beiwei Yu, Dong Dong, Mingxia Wang, Yan Guo, Dandan Yin, and Fupin Hu
|
| 29233-29237 |
|
| Pharmacogenetic studies with oral anticoagulants Genomewide association studies in vitamin K antagonist and direct oral anticoagulants |
|
https://doi.org/10.18632/oncotarget.25579
Natalia Cullell, Caty Carrera, Elena Muiño, Nuria Torres, Jerzy Krupinski, and Israel Fernandez-Cadenas
|
| 29238-29258 |
|
| Medicinal mushrooms as an attractive new source of natural compounds for future cancer therapy |
|
https://doi.org/10.18632/oncotarget.25660
Artem Blagodatski, Margarita Yatsunskaya, Valeriia Mikhailova, Vladlena Tiasto, Alexander Kagansky, and Vladimir L. Katanaev
|
| 29259-29274 |
|
| Papillary thyroid microcarcinoma Black Ink |
|
https://doi.org/10.18632/oncotarget.25621
Ersilio Trapanese, Carmine De Bartolomeis, Basilio Angrisani, and Giulio Tarro
|
| 29275-29283 |
|
| Correction: Resistance to anticancer vaccination effect is controlled by a cancer cellautonomous phenotype that disrupts immunogenic phagocytic removal |
|
https://doi.org/10.18632/oncotarget.25721
Abhishek D. Garg, Sanne Elsen, Dmitri V. Krysko, Peter Vandenabeele, Peter de Witte, and Patrizia Agostinis
|
| 29284-29284 |
|
| Correction: Evaluating prognosis by CK7 differentiating renal cell carcinomas from oncocytomas can be used as a promising tool for optimizing diagnosis strategies |
|
https://doi.org/10.18632/oncotarget.25726
Fuling Ma, Liang Dai, Zhun Wang, Liqun Zhou, Yuanjie Niu, and Ning Jiang
|
| 29285-29285 |
